GLP-3R

Price range: $36.00 through $140.00


Available in 10mg, 20mg, 30mg, and 50mg

Order within –h –m –s to ship on Tuesday, November 17.
10:00 AM ET cutoff • In-stock products only

LOT-SPECIFIC TESTING

Verified Test Results


Lot-Specific COA

Parameter Result Specification
Appearance


Good

Meets spec
Purity


99.85%
· Pass

≥ 95%
Identity


Confirmed

Meets spec
Fentanyl Screen


Not Detected

Pass
Heavy Metals


Not Detected

Pass
Sterility


No Growth

Pass
Lot
RE100-0413
Laboratory
Janoshik Analytical

Results shown apply to the listed product lot. Review the full certificate for complete testing information.

Description

GLP-3R Research Compound

GLP-3R is listed by East Coast Peptides as a retatrutide research material. The product is available in labeled 10 mg, 20 mg, 30 mg and 50 mg formats for controlled laboratory research.

Research Context

Published structural research on retatrutide examines interactions with GLP-1, GIP and glucagon receptors. Work performed with separately characterized study materials does not establish the identity, receptor activity or performance of a specific ECP product lot. Researchers should use appropriate reference materials, controls and validated methods when evaluating any test material.

Lot-Specific Documentation

Review the ECP COA Catalog for available reports. Each report applies only to the product lot identified in that document; availability and reported results may differ between lots. Analytical results do not establish biological outcomes.

Research Information

Explore general compound research topics in the ECP Research Blog.

Research use only. Not for human or veterinary use. Not intended for consumption, diagnosis, treatment or prevention of disease.

Additional information

Volume

10mg, 20mg, 30mg, 50mg

Reviews

There are no reviews yet.

Be the first to review “GLP-3R”

Your email address will not be published. Required fields are marked *

This product is currently sold out. Don't worry! Enter your email and we'll notify you when it's available again.